Skip to main content
. 2013 May 27;2013:965312. doi: 10.1155/2013/965312

Figure 4.

Figure 4

ATG treatment suppressed pigment deposition without affecting cell migration. Moderate concentration of ATG (10 μM) treated embryos showed reduced embryonic pigmentation without causing any discernible pigment cells migration defect (red arrowhead). Treatment of high dose ATG (100 μM) caused severe embryonic developmental retardation and growth was stalled at 18–20 somite stage (data not shown). All live embryos were treated with ATG for different dosages at 15 hpf (12–14 somite stage) followed by taken picture at 40 hpf. Pictures were shown by overview (a) and lateral view (b).